ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

39,392Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 939

$1.73M Total Retail Price of All Prescriptions

Rank: 7 out of 939

1,166 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,166 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 1,166 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 28,512 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
AMLODIPINE BESYLATE 1,612 1,249 1 6
HYDROCODONE-ACETAMINOPHEN 1,454 874 S3 2 1
SIMVASTATIN 1,401 1,031 3 2
OMEPRAZOLE 1,183 841 4 5
LISINOPRIL 1,142 871 5 3
FUROSEMIDE 1,122 932 6 7
GLIMEPIRIDE 953 729 7 37
LEVOTHYROXINE SODIUM 849 637 8 4
POTASSIUM CHLORIDE 848 688 9 9
GABAPENTIN 799 539 10 11
METOPROLOL TARTRATE 754 603 11 10
WARFARIN SODIUM 730 649 12 17
METFORMIN HCL 708 480 13 8
TRAMADOL HCL 620 419 14 16
MELOXICAM 590 419 15 14
METOPROLOL SUCCINATE 568 451 16 21
CITALOPRAM HBR 499 368 17 15
HYDROCHLOROTHIAZIDE 451 340 18 12
NEXIUM 435 228 19 18
LOSARTAN POTASSIUM 426 298 20 29
SERTRALINE HCL 418 325 21 24
AZITHROMYCIN 411 280 22 32
CLOPIDOGREL 380 320 23 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 352 278 24 23
TAMSULOSIN HCL 349 263 25 27
CLONIDINE HCL 343 236 26 39
DIGOXIN 341 276 27 45
DONEPEZIL HCL 327 327 28 30
LANTUS 314 202 29 59
ISOSORBIDE MONONITRATE ER 306 272 30 53
METHYLPREDNISOLONE 305 211 31 118
MIRTAZAPINE 297 259 32 56
TRIAMTERENE-HCTZ 293 205 33 33
ALLOPURINOL 272 229 34 31
CYCLOBENZAPRINE HCL 264 105 R 35 36
PANTOPRAZOLE SODIUM 262 184 36 66
CARVEDILOL 255 215 37 25
ATENOLOL 251 232 38 19
CRESTOR 251 165 38 34
ATORVASTATIN CALCIUM 246 217 40 22
PRAVASTATIN SODIUM 238 190 41 13
DIOVAN 226 192 42 50
CIPROFLOXACIN HCL 222 170 43 54
PLAVIX 218 174 44 48
TRAZODONE HCL 218 132 44 26
LOSARTAN-HYDROCHLOROTHIAZIDE 216 182 46 55
INSULIN SYRINGE 215 160 47 97
POLYETHYLENE GLYCOL 3350 214 193 48 57
AMLODIPINE BESYLATE-BENAZEPRIL 209 163 49 58
CYMBALTA 208 78 50 44
VERAPAMIL ER 196 175 51 85
CARISOPRODOL 195 15 R 52 51
AMITRIPTYLINE HCL 194 99 R 53 38
ZOLPIDEM TARTRATE 193 126 54 20
RISPERIDONE 184 126 55 82
ESCITALOPRAM OXALATE 184 127 55 61
PREDNISONE 183 146 57 42
LOVASTATIN 176 144 58 46
NAMENDA 174 174 59 49
PROAIR HFA 166 93 60 41
SPIRIVA 165 71 61 73
QUETIAPINE FUMARATE 160 126 62 69
ADVAIR DISKUS 156 82 63 60
MECLIZINE HCL 150 127 64 134
DOXYCYCLINE HYCLATE 149 111 65 84
ZETIA 149 100 65 103
RANITIDINE HCL 146 96 67 35
KLOR-CON M20 146 122 67 90
CARBIDOPA-LEVODOPA 145 126 69 102
EXELON 139 139 70 151
LEVOFLOXACIN 138 88 71 86
FENTANYL 135 91 S2 72 104
TRIAMCINOLONE ACETONIDE 132 99 73 150
LYRICA 127 69 74 63
PAROXETINE HCL 125 70 75 70
FLUOXETINE HCL 124 48 76 47
OXYCODONE HCL-ACETAMINOPHEN 123 61 S2 77 107
DILTIAZEM ER 119 98 78 94
DIOVAN HCT 119 98 78 74
ALENDRONATE SODIUM 119 94 78 40
ROPINIROLE HCL 118 97 81 78
KLOR-CON M10 118 109 81 163
AMOXICILLIN 117 71 83 92
FLUTICASONE PROPIONATE 116 85 84 43
AMIODARONE HCL 114 103 85 160
BUSPIRONE HCL 110 84 86 123
PROMETHAZINE HCL 108 30 R 87 68
SINGULAIR 108 26 87 101
GEMFIBROZIL 107 73 89 100
PHENYTOIN SODIUM EXTENDED 104 58 90 99
BENAZEPRIL HCL 101 62 91 87
AMOX TR-POTASSIUM CLAVULANATE 101 77 91 144
VENTOLIN HFA 99 52 93 80
DIVALPROEX SODIUM 99 38 93 95
SPIRONOLACTONE 97 52 95 71
RAMIPRIL 97 83 95 91
METRONIDAZOLE 90 63 97 238
HYDRALAZINE HCL 89 82 98 130
CLINDAMYCIN HCL 88 55 99 283
COMBIVENT 87 76 100 120
OLANZAPINE 86 66 101 135
METOCLOPRAMIDE HCL 85 40 102 119
FLUCONAZOLE 85 51 102 140
HYDROXYZINE PAMOATE 84 19 R 104 220
LEVEMIR 84 51 104 168
ESTRADIOL 84 33 R 104 79
DIVALPROEX SODIUM ER 81 27 107 146
FENOFIBRATE 80 61 108 83
TRICOR 80 46 108 143
HUMULIN 70-30 79 48 110 200
SUCRALFATE 76 43 111 96
AGGRENOX 76 76 111 153
SYMBICORT 76 35 111 137
PROPRANOLOL HCL 74 38 114 117
EVISTA 74 70 114 122
FLOVENT HFA 71 54 116 285
ENDOCET 70 14 S2 117 148
TIZANIDINE HCL 69 18 118 81
LOVAZA 69 30 118 191
THEOPHYLLINE ANHYDROUS 69 27 118 225
VENLAFAXINE HCL ER 67 24 121 121
FAMOTIDINE 67 56 121 62
NYSTATIN 66 54 123 174
EXFORGE 66 66 123 176
OXYBUTYNIN CHLORIDE ER 66 66 123 167
OXYCODONE-ACETAMINOPHEN 65 46 S2 126 138
MONTELUKAST SODIUM 64 25 127 172
SYNTHROID 64 59 127 75
GLIPIZIDE 63 55 129 52
NITROSTAT 62 47 130 204
NITROFURANTOIN MONO-MACRO 58 46 131 180
CYPROHEPTADINE HCL 57 46 R 132 318
LEVEMIR FLEXPEN 57 29 132 190
LIPITOR 57 44 132 127
ALBUTEROL SULFATE 57 38 132 171
LATANOPROST 57 55 132 233
LEXAPRO 57 42 132 201
NIFEDIPINE ER 57 46 132 105
TRIAMTERENE-HYDROCHLOROTHIAZID 56 38 139 115
ISOSORBIDE DINITRATE 56 52 139 273
NOVOLIN 70-30 55 41 141 211
CELEBREX 55 36 141 106
VENLAFAXINE HCL 53 41 143 159
HUMALOG 52 25 144 215
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 38 145 64
BENICAR 51 40 145 222
NOVOLOG 51 21 145 145
BENICAR HCT 50 34 148 243
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.